Coronavirus: Russia eyes German firm as co-partner in Sputnik V vaccine production

Russia has reached out to German biotechnology company IDT Biologika to explore jointly producing the Sputnik V coronavirus vaccine, the German health ministry said Wednesday.It comes a day after The Lancet journal published trial results showing the Sputnik vaccine to be 91.6 per cent effective against Covid-19, defying international scepticism about the Russian-made jab.Russia’s Sputnik V vaccine 91.6 per cent effective: Lancet studyA German health ministry spokeswoman said that Russia’s…

Read the original article at South China Morning Post